Literature DB >> 31303108

Procedural and Anatomical Determinants of Multielectrode Renal Denervation Efficacy.

Abraham R Tzafriri1, Felix Mahfoud2, John H Keating3, Anna-Maria Spognardi4, Peter M Markham4, Gee Wong3, Debby Highsmith5, Patrick O'Fallon5, Kristine Fuimaono5, Elazer R Edelman6,7.   

Abstract

Radiofrequency renal denervation is under investigation for treatment of hypertension with variable success. We developed preclinical models to examine the dependence of ablation biomarkers on renal denervation treatment parameters and anatomic variables. One hundred twenty-nine porcine renal arteries were denervated with an irrigated radiofrequency catheter with multiple helically arrayed electrodes. Nerve effects and ablation geometries at 7 days were characterized histomorphometrically and correlated with associated renal norepinephrine levels. Norepinephrine exhibited a threshold dependence on the percentage of affected nerves across the range of treatment durations (30-60 s) and power set points (6-20 W). For 15 W/30 s treatments, norepinephrine reduction and percentage of affected nerves tracked with number of electrode treatments, confirming additive effects of helically staggered ablations. Threshold effects were only attained when ≥4 electrodes were powered. Histomorphometry and computational modeling both illustrated that radiofrequency treatments directed at large neighboring veins resulted in subaverage ablation areas and, therefore, contributed suboptimally to efficacy. Account for measured nerve distribution patterns and the annular geometry of the artery revealed that, regardless of treatment variables, total ablation area and circumferential coverage were the prime determinants of renal denervation efficacy, with increased efficacy at smaller diameters.

Entities:  

Keywords:  catheter ablation; hypertension; models, animal; norepinephrine; renal artery

Mesh:

Substances:

Year:  2019        PMID: 31303108      PMCID: PMC6738948          DOI: 10.1161/HYPERTENSIONAHA.119.12918

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Renal artery nerve distribution and density in the porcine model: biologic implications for the development of radiofrequency ablation therapies.

Authors:  Armando Tellez; Serge Rousselle; Taylor Palmieri; William R Rate; Joan Wicks; Ashley Degrange; Chelsea M Hyon; Carlos A Gongora; Randy Hart; Will Grundy; Greg L Kaluza; Juan F Granada
Journal:  Transl Res       Date:  2013-07-30       Impact factor: 7.012

2.  Catheter-based renal denervation: the black box procedure.

Authors:  Felix Mahfoud; Deepak L Bhatt
Journal:  JACC Cardiovasc Interv       Date:  2013-10       Impact factor: 11.195

3.  Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial.

Authors:  Murray D Esler; Henry Krum; Markus Schlaich; Roland E Schmieder; Michael Böhm; Paul A Sobotka
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

4.  Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

Authors:  David E Kandzari; Deepak L Bhatt; Sandeep Brar; Chandan M Devireddy; Murray Esler; Martin Fahy; John M Flack; Barry T Katzen; Janice Lea; David P Lee; Martin B Leon; Adrian Ma; Joseph Massaro; Laura Mauri; Suzanne Oparil; William W O'Neill; Manesh R Patel; Krishna Rocha-Singh; Paul A Sobotka; Laura Svetkey; Raymond R Townsend; George L Bakris
Journal:  Eur Heart J       Date:  2014-11-16       Impact factor: 29.983

5.  Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Authors:  Michel Azizi; Roland E Schmieder; Felix Mahfoud; Michael A Weber; Joost Daemen; Justin Davies; Jan Basile; Ajay J Kirtane; Yale Wang; Melvin D Lobo; Manish Saxena; Lida Feyz; Florian Rader; Philipp Lurz; Jeremy Sayer; Marc Sapoval; Terry Levy; Kintur Sanghvi; Josephine Abraham; Andrew S P Sharp; Naomi D L Fisher; Michael J Bloch; Helen Reeve-Stoffer; Leslie Coleman; Christopher Mullin; Laura Mauri
Journal:  Lancet       Date:  2018-05-23       Impact factor: 79.321

6.  Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Authors:  Henry Krum; Markus P Schlaich; Paul A Sobotka; Michael Böhm; Felix Mahfoud; Krishna Rocha-Singh; Richard Katholi; Murray D Esler
Journal:  Lancet       Date:  2013-11-07       Impact factor: 79.321

7.  Anatomical and procedural determinants of catheter-based renal denervation.

Authors:  Sebastian Ewen; Christian Ukena; Thomas Felix Lüscher; Martin Bergmann; Peter J Blankestijn; Erwin Blessing; Bodo Cremers; Oliver Dörr; Dagmara Hering; Lukas Kaiser; Holger Nef; Elias Noory; Markus Schlaich; Faisal Sharif; Isabella Sudano; Britta Vogel; Michiel Voskuil; Thomas Zeller; Abraham R Tzafriri; Elazer R Edelman; Lucas Lauder; Bruno Scheller; Michael Böhm; Felix Mahfoud
Journal:  Cardiovasc Revasc Med       Date:  2016-08-20

8.  Accurate Depth of Radiofrequency-Induced Lesions in Renal Sympathetic Denervation Based on a Fine Histological Sectioning Approach in a Porcine Model.

Authors:  Atsushi Sakaoka; Hisako Terao; Shintaro Nakamura; Hitomi Hagiwara; Toshihito Furukawa; Kiyoshi Matsumura; Kenichi Sakakura
Journal:  Circ Cardiovasc Interv       Date:  2018-02       Impact factor: 6.546

9.  Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.

Authors:  Raymond R Townsend; Felix Mahfoud; David E Kandzari; Kazuomi Kario; Stuart Pocock; Michael A Weber; Sebastian Ewen; Konstantinos Tsioufis; Dimitrios Tousoulis; Andrew S P Sharp; Anthony F Watkinson; Roland E Schmieder; Axel Schmid; James W Choi; Cara East; Anthony Walton; Ingrid Hopper; Debbie L Cohen; Robert Wilensky; David P Lee; Adrian Ma; Chandan M Devireddy; Janice P Lea; Philipp C Lurz; Karl Fengler; Justin Davies; Neil Chapman; Sidney A Cohen; Vanessa DeBruin; Martin Fahy; Denise E Jones; Martin Rothman; Michael Böhm
Journal:  Lancet       Date:  2017-08-28       Impact factor: 79.321

10.  Procedural and anatomical predictors of renal denervation efficacy using two radiofrequency renal denervation catheters in a porcine model.

Authors:  Milan Wolf; Brad Hubbard; Atsushi Sakaoka; Serge Rousselle; Armando Tellez; Xiongjing Jiang; Kazuomi Kario; Mathias Hohl; Michael Böhm; Felix Mahfoud
Journal:  J Hypertens       Date:  2018-12       Impact factor: 4.844

View more
  6 in total

Review 1.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

2.  Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model.

Authors:  Márcio Galindo Kiuchi; Kavitha Ganesan; John Keating; Revathy Carnagarin; Vance B Matthews; Lakshini Y Herat; Gerard Goh; Leon Adams; Markus P Schlaich
Journal:  Clin Res Cardiol       Date:  2021-02-26       Impact factor: 5.460

3.  Morphometric analysis of the human common hepatic artery reveals a rich and accessible target for sympathetic liver denervation.

Authors:  Abraham Rami Tzafriri; Fernando Garcia-Polite; John Keating; Raffaele Melidone; Jennifer Knutson; Peter Markham; Elazer R Edelman; Felix Mahfoud
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

4.  Pulmonary and Systemic Hemodynamics following Multielectrode Radiofrequency Catheter Renal Denervation in Acutely Induced Pulmonary Arterial Hypertension in Swine.

Authors:  Aleksandr D Vakhrushev; Heber Ivan Сondori Leonardo; Natalia S Goncharova; Lev E Korobchenko; Lubov B Mitrofanova; Elizaveta M Andreeva; Elena G Koshevaya; Dmitry S Lebedev; Evgeny N Mikhaylov
Journal:  Biomed Res Int       Date:  2021-11-02       Impact factor: 3.411

Review 5.  Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.

Authors:  Hao Zhou; Yanping Xu; Weijie Chen; Liang Wang; Huaan Du; Hang Liu; Zhiyu Ling; Yuehui Yin
Journal:  Int J Hypertens       Date:  2022-08-12       Impact factor: 2.434

6.  Epididymal Fat-Derived Sympathoexcitatory Signals Exacerbate Neurogenic Hypertension in Obese Male Mice Exposed to Early Life Stress.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Sundus Ghuneim; Nermin Ahmed; Eve R Schneider; Olivier Thibault; Jeffrey L Osborn; Analia S Loria
Journal:  Hypertension       Date:  2021-10-04       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.